CN107200706A - 一类氟取代的环丙胺类化合物及其制备方法、药物组合物和用途 - Google Patents
一类氟取代的环丙胺类化合物及其制备方法、药物组合物和用途 Download PDFInfo
- Publication number
- CN107200706A CN107200706A CN201610149958.6A CN201610149958A CN107200706A CN 107200706 A CN107200706 A CN 107200706A CN 201610149958 A CN201610149958 A CN 201610149958A CN 107200706 A CN107200706 A CN 107200706A
- Authority
- CN
- China
- Prior art keywords
- acid
- substituted
- trans
- fluoro
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 NC(CC=C1C(C(C2)C2c2ccccc2)=C1)(CC1)CC*1C(OCC1CCCCC1)=O Chemical compound NC(CC=C1C(C(C2)C2c2ccccc2)=C1)(CC1)CC*1C(OCC1CCCCC1)=O 0.000 description 5
- DMSRCENKGYJVKR-UHFFFAOYSA-N CC(C)(C)OC(C1=CC=CC(COC(N(CC2)C=CC2(CN(C(C2)C2c2ccccc2)C(C(F)(F)F)=O)F)O)C=C1)=O Chemical compound CC(C)(C)OC(C1=CC=CC(COC(N(CC2)C=CC2(CN(C(C2)C2c2ccccc2)C(C(F)(F)F)=O)F)O)C=C1)=O DMSRCENKGYJVKR-UHFFFAOYSA-N 0.000 description 1
- VGYOPZUFBXSADV-UHFFFAOYSA-N CC(C)c1ccc(COC(N(CC2)CCC2(CNC(C2)C2C2C=CC=CC2)F)=[O]=C)cc1 Chemical compound CC(C)c1ccc(COC(N(CC2)CCC2(CNC(C2)C2C2C=CC=CC2)F)=[O]=C)cc1 VGYOPZUFBXSADV-UHFFFAOYSA-N 0.000 description 1
- RWQIPRWXYODIJZ-MDCZIUGASA-N CCOC(N(CC1)CCC1(CNC1([C@@H]2C1)C2c1ccccc1)F)=O Chemical compound CCOC(N(CC1)CCC1(CNC1([C@@H]2C1)C2c1ccccc1)F)=O RWQIPRWXYODIJZ-MDCZIUGASA-N 0.000 description 1
- NGCAFPIUAYVGON-UHFFFAOYSA-N FC1(CNC(C2)C2c2ccccc2)CCN(CCCC2CCCCC2)CC1 Chemical compound FC1(CNC(C2)C2c2ccccc2)CCN(CCCC2CCCCC2)CC1 NGCAFPIUAYVGON-UHFFFAOYSA-N 0.000 description 1
- IJUVVFGCZRZNFB-UHFFFAOYSA-N NCC(CC1)(CCN1C(OCc1ccccc1)=O)F Chemical compound NCC(CC1)(CCN1C(OCc1ccccc1)=O)F IJUVVFGCZRZNFB-UHFFFAOYSA-N 0.000 description 1
- KMAUOABPKMWCJQ-UHFFFAOYSA-N O=C(CCc1ccccc1)N(CC1)CCC1(CNC(C1)C1c1ccccc1)F Chemical compound O=C(CCc1ccccc1)N(CC1)CCC1(CNC(C1)C1c1ccccc1)F KMAUOABPKMWCJQ-UHFFFAOYSA-N 0.000 description 1
- ODFVACDSZAVYEV-UHFFFAOYSA-N O=C(N(CC1)CCC1(CNC(C1)C1c1ccccc1)F)OCC1CCC1 Chemical compound O=C(N(CC1)CCC1(CNC(C1)C1c1ccccc1)F)OCC1CCC1 ODFVACDSZAVYEV-UHFFFAOYSA-N 0.000 description 1
- PKDLSEBVMNODFN-UHFFFAOYSA-N O=C(N(CC1)CCC1(CNC(C1)C1c1ccccc1)F)OCC1CCCC1 Chemical compound O=C(N(CC1)CCC1(CNC(C1)C1c1ccccc1)F)OCC1CCCC1 PKDLSEBVMNODFN-UHFFFAOYSA-N 0.000 description 1
- QMPZBVLKANVEFM-UHFFFAOYSA-N O=C(N(CC1)CCC1(CNC(C1)C1c1ccccc1)F)OCc1ccc[o]1 Chemical compound O=C(N(CC1)CCC1(CNC(C1)C1c1ccccc1)F)OCc1ccc[o]1 QMPZBVLKANVEFM-UHFFFAOYSA-N 0.000 description 1
- INISDZCPOZUWSE-UHFFFAOYSA-N O=C(N(CC1)CCC1(CNC1C(Cc(cc2)cc(F)c2F)CC1)I)OCc1ccccc1 Chemical compound O=C(N(CC1)CCC1(CNC1C(Cc(cc2)cc(F)c2F)CC1)I)OCc1ccccc1 INISDZCPOZUWSE-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/24—Preparation of compounds containing amino groups bound to a carbon skeleton by reductive alkylation of ammonia, amines or compounds having groups reducible to amino groups, with carbonyl compounds
- C07C209/28—Preparation of compounds containing amino groups bound to a carbon skeleton by reductive alkylation of ammonia, amines or compounds having groups reducible to amino groups, with carbonyl compounds by reduction with other reducing agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
- C07C211/37—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/04—Formation of amino groups in compounds containing carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/41—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/43—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
- C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/20—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/38—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610149958.6A CN107200706A (zh) | 2016-03-16 | 2016-03-16 | 一类氟取代的环丙胺类化合物及其制备方法、药物组合物和用途 |
| PCT/CN2017/076967 WO2017157322A1 (zh) | 2016-03-16 | 2017-03-16 | 一类氟取代的环丙胺类化合物及其制备方法、药物组合物和用途 |
| RU2018136336A RU2746323C9 (ru) | 2016-03-16 | 2017-03-16 | Фторированное соединение циклопропиламина, способ получения, фармацевтическая композиция и ее использование |
| SG11201808017PA SG11201808017PA (en) | 2016-03-16 | 2017-03-16 | Fluorinated cyclopropylamine compound, preparation method therefor, pharmaceutical composition thereof, and users thereof |
| EP17765864.8A EP3431471A4 (en) | 2016-03-16 | 2017-03-16 | FLUORINATED CYCLOPROPYLAMINE COMPOUND, METHOD OF MANUFACTURING THEREOF, PHARMACEUTICAL COMPOSITION, AND USES THEREOF |
| KR1020187029900A KR102196050B1 (ko) | 2016-03-16 | 2017-03-16 | 불소로 치환된 시클로프로필아민계 화합물 및 이의 제조 방법, 약물 조성물 및 용도 |
| JP2018548895A JP7605579B2 (ja) | 2016-03-16 | 2017-03-16 | フッ素置換シクロプロピルアミン系化合物並びにその製造方法、薬物組成物及び使用 |
| US16/085,311 US10836743B2 (en) | 2016-03-16 | 2017-03-16 | Fluorinated cyclopropylamine compound, preparation method therefor, pharmaceutical composition thereof, and uses thereof |
| CN201780017669.3A CN108779096B (zh) | 2016-03-16 | 2017-03-16 | 一类氟取代的环丙胺类化合物及其制备方法、药物组合物和用途 |
| CA3021608A CA3021608C (en) | 2016-03-16 | 2017-03-16 | Fluorinated cyclopropylamine compound, preparation method therefor, pharmaceutical composition thereof, and uses thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610149958.6A CN107200706A (zh) | 2016-03-16 | 2016-03-16 | 一类氟取代的环丙胺类化合物及其制备方法、药物组合物和用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107200706A true CN107200706A (zh) | 2017-09-26 |
Family
ID=59850098
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610149958.6A Pending CN107200706A (zh) | 2016-03-16 | 2016-03-16 | 一类氟取代的环丙胺类化合物及其制备方法、药物组合物和用途 |
| CN201780017669.3A Active CN108779096B (zh) | 2016-03-16 | 2017-03-16 | 一类氟取代的环丙胺类化合物及其制备方法、药物组合物和用途 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201780017669.3A Active CN108779096B (zh) | 2016-03-16 | 2017-03-16 | 一类氟取代的环丙胺类化合物及其制备方法、药物组合物和用途 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10836743B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3431471A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7605579B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102196050B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN107200706A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3021608C (cg-RX-API-DMAC7.html) |
| RU (1) | RU2746323C9 (cg-RX-API-DMAC7.html) |
| SG (1) | SG11201808017PA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017157322A1 (cg-RX-API-DMAC7.html) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107459476A (zh) * | 2016-06-03 | 2017-12-12 | 中国科学院上海药物研究所 | 反吲哚啉环丙胺类化合物及其制备方法、药物组合物和用途 |
| CN109321940A (zh) * | 2018-11-30 | 2019-02-12 | 西南大学 | 一种酰胺的电化学氧化合成方法及其应用 |
| CN110248926A (zh) * | 2017-01-24 | 2019-09-17 | 南京明德新药研发有限公司 | Lsd1抑制剂及其制备方法和应用 |
| CN112939846A (zh) * | 2019-11-26 | 2021-06-11 | 中国科学院上海药物研究所 | 一种乙酰胆碱酯酶抑制剂的晶型及其制备方法和应用 |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017263361B2 (en) * | 2016-05-09 | 2021-08-05 | Jubilant Epicore LLC | Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors |
| US20190256930A1 (en) | 2016-11-03 | 2019-08-22 | Oryzon Genomics, S.A. | Biomarkers for determining responsiveness to lsd1 inhibitors |
| AU2018309372B2 (en) | 2017-08-03 | 2024-08-15 | Oryzon Genomics, S.A. | Methods of treating behavior alterations |
| SI3941466T1 (sl) | 2019-03-20 | 2026-04-30 | Oryzon Genomics, S.A. | Vafidemstat za zdravljenje neagresivnih simptomov mejne osebnostne motnje |
| HRP20251471T1 (hr) | 2019-03-20 | 2026-01-02 | Oryzon Genomics, S.A. | Postupci liječenja poremećaja hiperaktivnosti s deficitom pažnje korištenjem inhibitora kdm1a kao što je spoj vafidemstat |
| CN114341366A (zh) | 2019-07-05 | 2022-04-12 | 奥莱松基因组股份有限公司 | 用于使用kdm1a抑制剂个体化治疗小细胞肺癌的生物标志物和方法 |
| CA3231846A1 (en) | 2021-04-08 | 2022-10-13 | Tamara Maes | Combinations of lsd1 inhibitors for treating myeloid cancers |
| US20250275969A1 (en) | 2022-05-09 | 2025-09-04 | Oryzon Genomics, S.A. | Methods of treating malignant peripheral nerve sheath tumor (mpnst) using lsd1 inhibitors |
| US20250295660A1 (en) | 2022-05-09 | 2025-09-25 | Oryzon Genomics, S.A. | Methods of treating nf1-mutant tumors using lsd1 inhibitors |
| US20260151399A1 (en) | 2022-11-24 | 2026-06-04 | Oryzon Genomics, S.A. | Combinations of lsd1 inhibitors and menin inhibitors for treating cancer |
| CN118239883A (zh) * | 2022-12-22 | 2024-06-25 | 江苏联环药业股份有限公司 | 一类赖氨酸特异性脱甲基酶1(lsd1)抑制剂的制备方法 |
| CN118787751A (zh) * | 2023-04-12 | 2024-10-18 | 中国科学院上海药物研究所 | Lsd1抑制剂与药物联用治疗癌症的用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS55348B1 (sr) | 2010-04-19 | 2017-03-31 | Oryzon Gnomics S A | Inhibitori lizin specifične demetilaze-1 i njihova upotreba |
| DK2598482T3 (en) * | 2010-07-29 | 2018-06-14 | Oryzon Genomics Sa | ARYLCYCLOPROPYLAMINE-BASED DEMETHYLASE INHIBITORS OF LSD1 AND THEIR MEDICAL USE |
| MX347913B (es) * | 2011-03-25 | 2017-05-17 | Glaxosmithkline Intellectual Property (No 2) Ltd | Ciclopropilaminas como inhibidores de desmetilasa 1 especifica de lisina. |
| AU2012324803B9 (en) | 2011-10-20 | 2017-08-24 | Oryzon Genomics, S.A. | (hetero)aryl cyclopropylamine compounds as LSD1 inhibitors |
| US9469597B2 (en) | 2011-10-20 | 2016-10-18 | Oryzon Genomics S.A. | (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors |
| US9527835B2 (en) * | 2014-02-13 | 2016-12-27 | Incyte Corporation | Cyclopropylamines as LSD1 inhibitors |
| EP3392244A1 (en) * | 2014-02-13 | 2018-10-24 | Incyte Corporation | Cyclopropylamines as lsd1 inhibitors |
| LT3105218T (lt) | 2014-02-13 | 2019-12-10 | Incyte Corp | Ciklopropilaminai kaip lsd1 inhibitoriai |
| WO2015123424A1 (en) | 2014-02-13 | 2015-08-20 | Incyte Corporation | Cyclopropylamines as lsd1 inhibitors |
-
2016
- 2016-03-16 CN CN201610149958.6A patent/CN107200706A/zh active Pending
-
2017
- 2017-03-16 KR KR1020187029900A patent/KR102196050B1/ko active Active
- 2017-03-16 SG SG11201808017PA patent/SG11201808017PA/en unknown
- 2017-03-16 US US16/085,311 patent/US10836743B2/en active Active
- 2017-03-16 EP EP17765864.8A patent/EP3431471A4/en active Pending
- 2017-03-16 CN CN201780017669.3A patent/CN108779096B/zh active Active
- 2017-03-16 CA CA3021608A patent/CA3021608C/en active Active
- 2017-03-16 RU RU2018136336A patent/RU2746323C9/ru active
- 2017-03-16 WO PCT/CN2017/076967 patent/WO2017157322A1/zh not_active Ceased
- 2017-03-16 JP JP2018548895A patent/JP7605579B2/ja active Active
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107459476A (zh) * | 2016-06-03 | 2017-12-12 | 中国科学院上海药物研究所 | 反吲哚啉环丙胺类化合物及其制备方法、药物组合物和用途 |
| CN107459476B (zh) * | 2016-06-03 | 2022-06-24 | 中国科学院上海药物研究所 | 反吲哚啉环丙胺类化合物及其制备方法、药物组合物和用途 |
| CN110248926A (zh) * | 2017-01-24 | 2019-09-17 | 南京明德新药研发有限公司 | Lsd1抑制剂及其制备方法和应用 |
| US11433053B2 (en) | 2017-01-24 | 2022-09-06 | Medshine Discovery Inc. | LSD1 inhibitor and preparation method and application thereof |
| CN110248926B (zh) * | 2017-01-24 | 2022-12-06 | 石药集团中奇制药技术(石家庄)有限公司 | Lsd1抑制剂及其制备方法和应用 |
| CN109321940A (zh) * | 2018-11-30 | 2019-02-12 | 西南大学 | 一种酰胺的电化学氧化合成方法及其应用 |
| CN112939846A (zh) * | 2019-11-26 | 2021-06-11 | 中国科学院上海药物研究所 | 一种乙酰胆碱酯酶抑制剂的晶型及其制备方法和应用 |
| CN112939846B (zh) * | 2019-11-26 | 2023-12-26 | 中国科学院上海药物研究所 | 一种乙酰胆碱酯酶抑制剂的晶型及其制备方法和应用 |
| US12590061B2 (en) | 2019-11-26 | 2026-03-31 | Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences | Crystalline form of acetylcholinesterase inhibitor and preparation method therefor and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| JP7605579B2 (ja) | 2024-12-24 |
| US10836743B2 (en) | 2020-11-17 |
| CN108779096A (zh) | 2018-11-09 |
| SG11201808017PA (en) | 2018-11-29 |
| CA3021608A1 (en) | 2017-09-21 |
| CA3021608C (en) | 2021-09-07 |
| EP3431471A4 (en) | 2019-09-25 |
| KR20190003941A (ko) | 2019-01-10 |
| RU2746323C2 (ru) | 2021-04-12 |
| RU2746323C9 (ru) | 2021-07-01 |
| RU2018136336A3 (cg-RX-API-DMAC7.html) | 2020-04-16 |
| WO2017157322A1 (zh) | 2017-09-21 |
| CN108779096B (zh) | 2022-07-01 |
| EP3431471A1 (en) | 2019-01-23 |
| RU2018136336A (ru) | 2020-04-16 |
| JP2019515878A (ja) | 2019-06-13 |
| KR102196050B1 (ko) | 2020-12-30 |
| US20190100507A1 (en) | 2019-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108779096B (zh) | 一类氟取代的环丙胺类化合物及其制备方法、药物组合物和用途 | |
| EP1777218B1 (en) | Process for the preparation of 4-phenoxy quinoline derivatives | |
| KR102582021B1 (ko) | Gpr139의 모듈레이터로서의 4-옥소-3,4-디히드로-1,2,3-벤조트리아진 | |
| RU2337094C2 (ru) | Ацилированные арилциклоакиламины и их применение в качестве фармацевтических средств | |
| US20110053915A1 (en) | HETEROCYCLIC INHIBITORS OF AN Hh-SIGNAL CASCADE, MEDICINAL COMPOSITIONS BASED THEREON AND METHODS FOR TREATING DISEASES CAUSED BY THE ABERRANT ACTIVITY OF AN Hh-SIGNAL SYSTEM | |
| US20080255222A1 (en) | Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases | |
| CN105246887B (zh) | 香豆素衍生物以及用于治疗过度增生性疾病的方法 | |
| EA005819B1 (ru) | Фармацевтически активные производные сульфонамида, содержащие как липофильные, так и ионизируемые фрагменты, в качестве ингибиторов jun-протеинкиназ | |
| RS59534B1 (sr) | Ciklopropilamini kao lsd1 inhibitori | |
| CN101531638A (zh) | 用作雌激素相关受体调节剂的化合物及其应用 | |
| JP2017538676A (ja) | ミトコンドリア透過性遷移孔(mtPTP)の小分子阻害剤 | |
| JP6402115B2 (ja) | 神経学的疾患および状態の処置に有用なスピロ−キナゾリノン誘導体 | |
| US11873292B2 (en) | Trans-indoline cyclopropylamine chemical compound, and method for preparation, pharmaceutical composition, and use thereof | |
| JP2012520246A (ja) | Kcnq2/3モジュレータとしての置換された3−アミノイソオキサゾロピリジン | |
| CN107074856A (zh) | CaMKII抑制剂及其用途 | |
| WO2015096771A1 (zh) | 2-氧代-1,2-二氢苯并[cd]吲哚-6-磺酰胺类化合物及其组合物和应用 | |
| CN114478359B (zh) | 氨基甲酸酯类trpv1拮抗/faah抑制双靶点药物及其制备方法和应用 | |
| CN109336829A (zh) | 含1,2,3-三氮唑结构的芳基甲酰胺类化合物及其用途 | |
| AU2021301444A1 (en) | Quinazolinones derivatives for treatment of non-alcoholic fatty liver disease, preparation and use thereof | |
| US20190337956A1 (en) | Neuroactive compounds and methods of using same | |
| US20250368645A1 (en) | Beta carboline analogues as selective and biased kappa opioid receptors agonists for treating various associated pathophysiological conditions | |
| CN102076672A (zh) | 新型五元环化合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170926 |